Suggestions
Payal Divakaran
Payal Agrawal Divakaran is a Partner at .406 Ventures, a venture capital firm based in Boston.23 At .406 Ventures, she co-leads the digital health investing practice.23 The firm has over $1.4B under management and focuses on early-stage enterprise-focused startups in healthcare, data + AI, and cybersecurity.34 Payal joined .406 Ventures in 2015 and has a wide range of technology experience.5
Payal's investment portfolio includes AristaMD, Better Life Partners, Diana Health, Equip, Heartbeat Health, Nomad Health, Redox, Wayspring, WelbeHealth, Wellist, and Virtudent.2 She also holds board observer positions at Nema Health, Equip, AristaMD, Laudio, Wellist, WelbeHealth, Nomad_Health, and Redox Engine, and board member positions at Diana Health and Heartbeat Health.1
Before joining .406 Ventures, Payal co-founded SpotRocket, a company that helped students discover high-potential start-ups.25 She also worked in Corporate Development at Eventbrite and as an Associate at Spectrum Equity.5 Earlier in her career, Payal worked in technology investment banking at J.P. Morgan in NYC.5
Payal received her MBA, with Distinction, from Harvard Business School and her BS in Electrical Engineering and minor in Management from MIT.25 She lives in Brookline, Massachusetts, with her husband, who is a physician at Brigham and Women’s Hospital, and their two children.25
Highlights
#DHISeast last week had a sanguine vibe, reflecting the challenges and opportunities in healthcare. I enjoyed the opportunity to moderate a discussion about clinician burnout, hiring, and retention with Creagh Milford, DO, MPH at CVS Health, Elisa M. Vincent at Equip, Robert Gabbay MD, PhD at American Diabetes Association, and Russ Richmond at Laudio. We resisted the urge to talk about AI as the wholesale solution to these problems. While I believe in the promise of AI and GenAI in healthcare to yield great change, it will take time. While technology and AI usage is expanding, people will continue to be at the center of healthcare – the clinicians who are the lifeblood of our health care delivery ecosystem and the patients who are yearning for more access and better outcomes. We discussed the central role of humanity and how to combat the ‘moral injury’ that is being felt with actionable tactics from our panelists representing a variety of provider organizations.
Our discussion reinforced my perspective that one of the most important things we can do to positively impact all levels of the clinical workforce is to support our healthcare leaders (clinical and operational) to be better managers. Healthcare is a human business, and we must go back to basics on the human components of clinician hiring, development, and retention. To get this training and development right, strong HR leaders within clinical care delivery organizations are going to be more important than ever.
Years in the making, Kathryn Taylor Reddy and I describe the investment thesis around OncoveryCare below. In this piece, we share our view on the importance of timing — not only is it the right time for a new model of cancer survivorship care, but it was definitely worth waiting to partner with Hil Moss, Justin Grischkan, Natalie Dickson, and Stephen Schleicher!
https://lnkd.in/e_vB9v2Q
Rebecca Redfield .406 Ventures
